$RELX

RELX PLC

RELX is a global provider of information-based analytics and decision tools for professional and business customers, serving customers in more than 180 countries and territories. It operates four major market segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. Risk combines public and industry-specific information with technology and algorithms to help customers assess risk and improve operational efficiency. Scientific, Technical & Medical provides scientific and medical information, data and insights; Legal offers tools combining legal, regulatory and business information with analytics; and Exhibitions uses industry expertise, digital tools and data to help customers connect, discover markets and conduct business. RELX earns money from these products and services, which are now provided almost exclusively in electronic format, as well as from print and print-related activities. Its principal executive office is in London, England.

No enriched coverage for $RELX in the last 7 days.

No SEC Form 4 filings for $RELX in the last 30 days.

See all $RELX insider activity →
Low

RELX (RELX) Exit: Generative AI Headwinds Prompt Portfolio Sale

Hennessy Focus Fund exited its position in RELX PLC (NYSE:RELX), citing concerns about AI's impact on its core businesses. RELX closed at $39.40, up 19.70% in the past month but down 7.31% over 52 weeks. The fund prefers AI stocks with higher upside potential.

RELX Presents Strategy to Accelerate STM Revenue Growth

RELX reported 6% underlying revenue growth in its Scientific, Technical & Medical business for H1 2026, with adjusted operating profit up 8%. The segment contributed 28% of group revenue and 30% of profit. Elsevier saw a 20% rise in article submissions and 7% increase in published articles. The company aims to boost research publishing and product innovation to maintain profit growth ahead of revenue.

RELX sentiment & insider activity

Recent RELX coverage spans financial news, earnings and market movers.

What's driving RELX

AlphAI scores every news story that mentions RELX with an AI model for sentiment and relevance, and aggregates insider trades from RELX PLC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $RELX

Score

RELX Presents Strategy to Accelerate STM Revenue Growth

RELX reported 6% underlying revenue growth in its Scientific, Technical & Medical business for H1 2026, with adjusted operating profit up 8%. The segment contributed 28% of group revenue and 30% of profit. Elsevier saw a 20% rise in article submissions and 7% increase in published articles. The company aims to boost research publishing and product innovation to maintain profit growth ahead of revenue.

RELX PLC: Gets a Buy rating from JP Morgan

JP Morgan assigned a Buy rating to RELX PLC, based on a weighted average of valuation, EPS revisions, and visibility metrics. The company's shares were trading at 2,998 GBX, with a 1.35% decrease over 5 days and a 2.08% increase since the start of the year. UBS also reaffirmed its Buy rating on the same day.

$RELXHighAI 8/10

Relx defies AI disruption fears as growth holds firm

Relx reported a 7% rise in underlying revenue for the first nine months of 2026, with all divisions growing. Legal business saw the highest growth at 10%, driven by AI-powered research tools. The company maintained its full-year forecast for revenue, profit, and earnings per share. Relx argues its specialist data gives it an advantage over AI competitors. Shares have been volatile amid broader sector sell-offs.

Why is Relx stock climbing today?

Relx stock rose 2.6% to $37.87 in pre-market trading after Bank of America reaffirmed its Buy rating and GBp 4,000 price target, citing AI-driven growth and share buybacks. The company's AI tools, like Lexis+, are boosting sales, and analysts remain optimistic ahead of its October 22 update.

RELX PLC bought 746,868 of its own shares on the London Stock Exchange from 28 September to 2 October 2026, at an average price of 2503.5372 pence per share

RELX PLC bought 746,868 of its own shares on the London Stock Exchange from 28 September to 2 October 2026, at an average price of 2503.5372 pence per share. The shares will be held as treasury stock. The company now holds 86,076,451 shares in treasury and has 1,743,014,323 shares in issue, excluding treasury shares. Since 2 January 2026, RELX PLC has purchased 81,968,579 ordinary shares.

Related tickers